Stock Market News — October 23, 2026 — Morning Update — Last 12 Hours (Pacific Time)
Executive Summary
Markets navigated a turbulent session Friday as a SpaceX report to secure 80,000 U.S. cell sites reshuffled the telecom and tower sectors — crushing carriers while lifting infrastructure stocks — while a broader AI-linked selloff from Thursday continued to weigh on tech. European equities posted their steepest weekly loss since early September, dragged by French fiscal turmoil and a catastrophic earnings miss from Kering, whose shares fell as much as 16%. Cybersecurity stocks bucked the trend, rallying sharply on Evercore ISI demand data and escalating PHP vulnerability concerns.
Sentiment Breakdown
| Sentiment | Count | Percentage |
|---|---|---|
| 🟢 Bullish | 98 | ~36% |
| 🟡 Neutral | 52 | ~19% |
| 🔴 Bearish | 123 | ~45% |
Net Sentiment: Bearish — AI selloff hangover, European macro stress, telecom disruption fears, and multiple earnings disappointments outweigh pockets of strength in cybersecurity, tower stocks, and select IPOs.
Top Market-Moving Headlines
🔴 Macro/Europe | European stocks post steepest weekly loss since early September on France turmoil and oil prices
Market Impact: French fiscal unrest and Moody's ratings threat weighed heavily on the CAC 40 (−0.36%) and DAX (−0.86%); STOXX 600 extended its decline as earnings optimism faded.
🔴 Luxury/Earnings | Kering plunges up to 16% — worst day ever — as Gucci sales slide
Market Impact: The Gucci owner's Q3 revenue miss sent shockwaves through the luxury sector, reinforcing fears of a prolonged consumer spending slowdown heading into winter.
🔴 Telecom | SpaceX in talks to secure 80,000 U.S. cell sites — AT&T, T-Mobile, Verizon slide
Market Impact: AT&T fell ~5%, T-Mobile ~5.5%, and Verizon ~3.3% on fears SpaceX's terrestrial wireless ambitions could disrupt the incumbent carrier model.
🟢 Infrastructure | Tower stocks surge — Crown Castle jumps 7.5%, American Tower +3.3% on SpaceX cell-site talks
Market Impact: The same SpaceX report that crushed carriers was a direct windfall for tower operators, who stand to lease thousands of sites to the Elon Musk venture.
🔴 AI/Tech | Nasdaq rebounds modestly after Thursday's worst session since June; AI chip selloff called 'unmoored from fundamentals'
Market Impact: The Nasdaq edged higher Friday but remained under pressure; the S&P 500 tested key 7,670 support as investors digested the prior session's 2.6% Nasdaq plunge.
🟢 Cybersecurity | CrowdStrike +5.7%, Palo Alto Networks +5.9%, Okta +5.2%, SentinelOne +4.2%, Check Point +3.2% surge on AI-threat demand data
Market Impact: Evercore ISI's quarterly cybersecurity survey showed strengthening year-end demand, and an emergency PHP vulnerability affecting ~70% of global websites amplified the sector's urgency.
🟢 Biotech/Pharma | Genmab surges ~9% on positive Phase 3 ovarian cancer trial results
Market Impact: The Danish biotech's transformative data triggered a sector-wide reaction, with rival Corcept Therapeutics tumbling 12.9% on competitive threat implications.
🟢 IPO | Lycia Therapeutics surges ~33% in Nasdaq debut after upsized $317.5M IPO priced at $18
Market Impact: Shares opened at $28.55, signaling robust biotech IPO appetite despite broader market volatility; notably, half of investors reportedly received zero allocation.
🟢 Financials | American Express beats Q3 EPS ($5.42 vs. $4.58 est.), raises 2026 profit forecast
Market Impact: Strong affluent consumer spending drove the beat, though the stock slid ~2.4% after AmEx simultaneously announced plans to cut 5% of its total workforce.
🔴 Autos | Volvo Cars plunges ~27.9% to 52-week low, cuts 2,500 jobs as Q3 swings to a loss
Market Impact: One of the session's most dramatic single-stock moves; the Swedish EV maker's deteriorating financials underscore the broader pressure on legacy automakers transitioning to electric.
🔴 Autos/Earnings | GM stock fell ~8% on Oct. 20 earnings despite solid numbers; LKQ crashes ~13% on weak Q3 and CEO departure
Market Impact: Two separate auto-sector blowups in the same week signal investor anxiety about the sector's near-term earnings trajectory and leadership stability.
🟢 M&A/Biotech | Zymeworks surges 5.5% on $813M Roche licensing deal
Market Impact: A significant validation of Zymeworks' pipeline and a reminder that big pharma is actively deploying capital into biotech partnerships.
🔴 Semiconductors | Credo Technology falls ~8.7% on competition fears and slower 1.6T rollout; SK Hynix halts Solidigm U.S. IPO
Market Impact: MaxLinear commentary flagged competitive headwinds for Credo; SK Hynix's IPO pause benefits Micron and SanDisk per analyst notes.
🟢 Energy/Oilfield | SLB beats Q3 estimates, signals stronger 2027 on Middle East rebound
Market Impact: The oilfield services leader's upbeat outlook adds a constructive data point for energy sector bulls as oil prices hit a five-month high.
🔴 Macro/France | France faces Moody's ratings downgrade threat amid ongoing civil unrest
Market Impact: A potential sovereign downgrade would compound pressure on French assets and European credit markets, adding to the week's political risk premium.
🔴 Retail/Consumer | UK retail sales miss drives FTSE 100 to snap two-week winning streak (−0.39%)
Market Impact: Weak consumer data reinforced concerns about UK economic momentum, hitting retail and consumer-facing stocks disproportionately.
🟢 Macro/IPO | Jio IPO attracts $77 billion in bids — most subscribed Indian IPO ever
Market Impact: Mukesh Ambani's first IPO in 20 years signals massive emerging market investor appetite and could reshape India's telecom and tech investment landscape.
🔴 Software/Earnings | SS&C Technologies falls 6.9% on weak Q4 revenue guidance; Infosys ADR tumbles 7.8% after trimming outlook
Market Impact: Two IT/software names guiding lower in the same session reinforces caution around enterprise software spending heading into year-end.
🟢 Defense/Consulting | Booz Allen Hamilton beats fiscal Q2 estimates (EPS $1.76 vs. $1.48 est.) but stock falls 3.3%
Market Impact: A classic "buy the rumor, sell the news" reaction; the beat was strong but the stock's decline suggests elevated expectations had already been priced in.
🔴 Macro/AI | BofA flags growing investor reluctance to fund AI infrastructure; stays 'tactically risk-off' until mid-November
Market Impact: A high-profile strategic call from a major bank reinforcing the near-term caution narrative — stocks, yields, and the dollar all flagged for further downside.
Tickers in Focus
| Ticker | Price / Change | Context |
|---|---|---|
| PANW | $375.82 / +5.9% | Cybersecurity demand surge; Evercore ISI survey tailwind |
| CRWD | $251.55 / +5.7% | Same Evercore ISI cybersecurity demand catalyst |
| OKTA | $211.80 / +5.2% | Evercore ISI survey; cybersecurity sector rally |
| S (SentinelOne) | +4.2% | Rosenblatt price target raise |
| CHKP | $156.90 / +3.2% | Cybersecurity sector rally |
| KER (Kering) | −16% (up to) | Worst day ever; Gucci Q3 sales miss |
| GMAB | +9% | Positive Phase 3 ovarian cancer trial results |
| CORT | −12.9% | Competitive threat from Genmab trial data |
| LYCA | Opened $28.55 / IPO $18 / +~33% | Upsized $317.5M Nasdaq debut |
| AXP | ~$315.83 / −2.4% pre-open | Q3 EPS beat $5.42 vs $4.58; raised guidance; 5% workforce cut |
| T (AT&T) | −~5% | SpaceX cell-site expansion report |
| TMUS | −~5.5% | SpaceX cell-site expansion report |
| VZ | $43.70 / −~3.3% | SpaceX cell-site expansion report |
| CCI (Crown Castle) | +7.5% | SpaceX cell-site talks beneficiary |
| AMT (American Tower) | +3.3% | SpaceX cell-site talks beneficiary |
| VCAR (Volvo Cars) | SEK 10.18 / −27.9% | Q3 swings to loss; 2,500 job cuts; 52-week low |
| LKQ | −~13% | Weak Q3 results; CEO departure |
| GM | −~8% (Oct. 20) | Post-earnings drop despite solid numbers |
| ZYME | +5.5% | $813M Roche licensing deal |
| SSNC | −6.9% | Weak Q4 revenue guidance |
| INFY ADR | −7.8% | Trimmed revenue outlook |
| WDC | EPS $4.64 vs $4.08 est. / −1%+ | Beat but cost pressures and higher capex weighed |
| NEM | −2.5% | Beat Q3 but stock slid on headline reaction |
| DECK | $81.29 / −4.68% | Near 52-week low; post-earnings pressure |
| MBLY (Mobileye) | $6.45 / −7.2% | New 52-week low; SpaceX/auto tech headwinds |
| CRDO | $149.16 / −8.36% | Competition fears; slower 1.6T rollout |
| RHI (Robert Half) | +~10% | Q3 earnings beat; analyst target upgrades |
| CBOE | +~3% | $550M buyback boost |
| SLB | Beat Q3 | Strong demand; signals stronger 2027 |
| META | — | Non-voting Class C shares plan; BofA top AI pick; commercial terms delay |
| NFLX | $67.05 close / $66.63 pre-mkt | Near 52-week lows |
| NVDA | ~$210.39 | Testing Fibonacci support; AI selloff pressure |
| MSFT | Broke $523 cloud support | Bearish technical signal |
| AAPL | Near ATH | iPhone Duo launch day; bearish divergence warning |
| SK Hynix ADR | +5.1% | Strong HBM earnings; Solidigm IPO halted |
| BAH | −3.3% | Beat estimates but sold off post-earnings |
| BE (Bloom Energy) | −~12% | Post-earnings selloff despite strong Q3 beat |
| SBA Communications | $190.63 / +~6.9% | SpaceX tower beneficiary |
| SAFN (Safran) | €282.8 / −6.4% | Q3 results disappointed |
| INTRUM | SEK 2.1 / −23.4% | Q3 results collapse |
Market Implications
The SpaceX cell-site story is the week's most structurally significant development for U.S. telecom. If SpaceX secures 80,000 sites and builds a competing nationwide wireless network, the competitive moat that AT&T, T-Mobile, and Verizon have spent decades constructing faces a genuine long-term threat. The immediate trade — short carriers, long tower operators — played out violently on Friday, but the longer-term question is whether SpaceX can actually execute at scale, and whether regulators will intervene. This story will dominate telecom sector discussion well into 2027.
The AI infrastructure funding debate is intensifying at exactly the wrong moment. BofA's "tactically risk-off" call, Meta's surprise non-voting share issuance to fund AI capex, and Thursday's Nasdaq plunge collectively suggest the market is beginning to scrutinize the return on AI investment more critically. The Evercore ISI cybersecurity survey provided a rare bright spot — AI-powered threats are accelerating demand for security software even as broader AI infrastructure spending faces skepticism. Cybersecurity may be the most defensible AI-adjacent trade heading into Q4.
European markets face a compounding set of headwinds into next week: French political instability, a potential Moody's downgrade, Kering's luxury sector warning, and oil at a five-month high squeezing margins. With the DAX breaking below 25,200 and the STOXX 600 posting its worst weekly performance since early September, the near-term technical and fundamental picture for European equities looks challenged. Next week's earnings slate — including ExxonMobil, Chevron, AbbVie, Sanofi, and BP — will be critical in determining whether the selloff broadens or stabilizes.
Key Takeaways
- 🔴 Kering (KER) — Down up to 16%, worst day ever; Gucci's Q3 miss signals luxury sector entering a tough winter
- 🟢 Cybersecurity sector — PANW, CRWD, OKTA, S, CHKP all surged 3–6% on Evercore demand data and PHP vulnerability emergency
- 🔴 AT&T / T-Mobile / Verizon — Each fell 3–5.5%; SpaceX's 80,000 cell-site ambition is an existential competitive threat narrative
- 🟢 Crown Castle / American Tower / SBA Communications — Tower operators are the direct beneficiaries of SpaceX's terrestrial expansion plans
- 🔴 Volvo Cars — Plunged 27.9% to a 52-week low; Q3 loss and 2,500 job cuts make it one of the worst single-day auto collapses in recent memory
- 🟢 Genmab (GMAB) — Phase 3 ovarian cancer trial success drove a 9% surge; Corcept Therapeutics paid the price with a 12.9% drop
- 🟢 Lycia Therapeutics (LYCA) — Biotech IPO market still alive; +33% debut on upsized $317.5M deal
- 🟢 American Express (AXP) — Q3 EPS beat of 18.3% and raised guidance, but 5% workforce cut announcement tempered enthusiasm
- 🔴 Nasdaq/AI chips — Thursday's 2.6% Nasdaq plunge labeled "unmoored from fundamentals" by one analyst; Friday's partial recovery remains fragile
- 🔴 LKQ — Down ~13% on weak Q3 and CEO departure; double-hit that rarely ends well short-term
- 🟢 Zymeworks (ZYME) — $813M Roche licensing deal validates pipeline and provides near-term cash runway
- 🔴 SS&C Technologies / Infosys ADR — Both guided lower; enterprise software spending caution is a real theme heading into year-end
- 🟢 Jio IPO — $77B in bids makes it India's most subscribed IPO ever; massive signal for emerging market capital appetite
- 🔴 France macro — Moody's downgrade threat + civil unrest + CAC 40 weekly loss = elevated political risk premium on European assets
- 🟢 SLB — Beat Q3 and signaled stronger 2027 on Middle East rebound; constructive for energy services sector
- 🔴 Bloom Energy (BE) — Down ~12% despite a strong Q3 beat; market punishing guidance or valuation concerns
- 🟢 Robert Half (RHI) — Up ~10% on Q3 beat; a rare bright spot in a week of earnings disappointments
- 🔴 Credo Technology (CRDO) — Down ~8.7% on competition fears and slower 1.6T ethernet rollout timeline
- 🟡 Meta (META) — Non-voting share plan to fund AI capex raises governance concerns; BofA named it a top AI idea despite the controversy
- 🔴 BofA macro call — "Tactically risk-off until mid-November" with downside flagged for stocks, yields, and the dollar — a significant near-term headwind signal
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Insider transactions can have many motivations beyond stock outlook.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/